Diseases in Mark's patent
Explore autoimmune, cancer, neurological, respiratory, and other conditions named in Mark Egly's patent. Filter by category to find education pages with research hypotheses clearly labeled.
Research hypothesis, not medical advice
The connections described on this page come from Mark Egly's patent filing and ongoing research. They are not established medical facts. Always work with your physician for diagnosis and treatment.
- Acute disseminated encephalomyelitis
Education on Acute disseminated encephalomyelitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Acute Respiratory Distress Syndrome
Education on Acute Respiratory Distress Syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Addison's disease
Education on Addison's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Adiposis dolorosa
Education on Adiposis dolorosa and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Adult-onset Still's disease
Education on Adult-onset Still's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Alopecia areata
Education on Alopecia areata and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Alzheimer's disease
Hypothesis labeled education on Alzheimer's disease within Mark Egly Foundation neurological research pages.
- Amyotrophic lateral sclerosis
Also known as: ALS, Lou Gehrig's Disease
Education on Amyotrophic lateral sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Anemia and thrombocytopenia
Education on Anemia and thrombocytopenia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Aneurysms
Education on Aneurysms and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Ankylosing spondylitis
Education on Ankylosing spondylitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Anti-glomerular basement membrane nephritis
Education on Anti-glomerular basement membrane nephritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Anti-N-methyl-D-aspartate receptor encephalitis
Education on Anti-N-methyl-D-aspartate receptor encephalitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Anti-neutrophil cytoplasmic antibody-associated vasculitis
Education on Anti-neutrophil cytoplasmic antibody-associated vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Antiphospholipid syndrome
Education on Antiphospholipid syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Antisynthetase syndrome
Education on Antisynthetase syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Aplastic anemia
Education on Aplastic anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Atherosclerosis
Education on Atherosclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune angioedema
Education on Autoimmune angioedema and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune enteropathy
Education on Autoimmune enteropathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune hemolytic anemia
Education on Autoimmune hemolytic anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune hepatitis
Education on Autoimmune hepatitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune lymphoproliferative syndrome
Education on Autoimmune lymphoproliferative syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune neutropenia
Education on Autoimmune neutropenia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune oophoritis
Education on Autoimmune oophoritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune orchitis
Education on Autoimmune orchitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune pancreatitis
Education on Autoimmune pancreatitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune polyendocrine syndrome
Education on Autoimmune polyendocrine syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune polyendocrine syndrome type 2
Education on Autoimmune polyendocrine syndrome type 2 and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune polyendocrine syndrome type 3
Education on Autoimmune polyendocrine syndrome type 3 and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune progesterone dermatitis
Education on Autoimmune progesterone dermatitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune retinopathy
Education on Autoimmune retinopathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune thrombocytopenic purpura
Education on Autoimmune thrombocytopenic purpura and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune thyroiditis
Education on Autoimmune thyroiditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune urticaria
Education on Autoimmune urticaria and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Autoimmune uveitis
Education on Autoimmune uveitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Balo concentric sclerosis
Education on Balo concentric sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Behcet's disease
Education on Behcet's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Bone marrow disease
Education on Bone marrow disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Breast cancer
Education on breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Bullous pemphigoid
Education on Bullous pemphigoid and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Cancer
Education on Cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Celiac disease
Education on Celiac disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Chronic fatigue syndrome
Education on Chronic fatigue syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Chronic inflammatory demyelinating polyneuropathy
Education on Chronic inflammatory demyelinating polyneuropathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Churg-Strauss syndrome
Education on Churg-Strauss syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Cicatrical pemphigoid
Education on Cicatrical pemphigoid and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Circulation problems
Education on Circulation problems and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Cogan's syndrome
Also known as: autoimmune inner ear disease
Education on Cogan's syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Cold agglutinin disease
Education on Cold agglutinin disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Colorectal cancer
Education on Colorectal cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Complex regional pain syndrome
Education on Complex regional pain syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- COPD
Also known as: Chronic Obstructive Pulmonary Disease, Alpha-1 COPD
Education on COPD as a common lung outcome of Alpha-1 Antitrypsin Deficiency, with guidance on symptoms, testing, and established care pathways.
- Coronavirus
Education on Coronavirus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Crest syndrome
Also known as: limited scleroderma
Education on Crest syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Crohn's disease
Education on Crohn's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Cushing's disease
Education on Cushing's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Cystic fibrosis
Education on Cystic fibrosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Demyelinating diseases
Education on Demyelinating diseases and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Depression
Education on Depression and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Dermatitis herpetiformis
Education on Dermatitis herpetiformis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Dermatomyositis
Education on Dermatomyositis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Diabetes
Education on Diabetes and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Diabetes mellitus type 1
Education on Diabetes mellitus type 1 and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Discoid lupus erythematosus
Education on Discoid lupus erythematosus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Ductal carcinoma in Situ
Also known as: DCIS, breast cancer
Education on Ductal carcinoma in Situ and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Ears and hearing
Education on Ears and hearing and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Eclampsia, preeclampsia, and hypertension
Education on Eclampsia, preeclampsia, and hypertension and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Emphysema
Also known as: Hereditary emphysema, Alpha-1 emphysema
Education on emphysema and hereditary emphysema linked to Alpha-1 Antitrypsin Deficiency, including testing and care pathways.
- Endometriosis
Education on Endometriosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Enthesitis
Education on Enthesitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Enthesitis-related arthritis
Education on Enthesitis-related arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Eosinophilic esophagitis
Education on Eosinophilic esophagitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Eosinophilic fasciitis
Education on Eosinophilic fasciitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Epidermolysis bullosa acquisita
Education on Epidermolysis bullosa acquisita and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Epilepsy
Education on Epilepsy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Erythema nodosum
Education on Erythema nodosum and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Esophagus and GERD
Education on Esophagus and GERD and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Essential mixed cryoglobulinemia
Education on Essential mixed cryoglobulinemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Evans syndrome
Education on Evans syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Eyes
Education on Eyes and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Fibromyalgia
Education on Fibromyalgia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Fibrosis
Education on Fibrosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Gastritis
Education on Gastritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Gestational pemphigoid
Education on Gestational pemphigoid and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Giant cell arteritis
Education on Giant cell arteritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Graves disease
Education on Graves disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Graves ophthalmopathy
Education on Graves ophthalmopathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Guillain-Barre syndrome
Education on Guillain-Barre syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Hashimoto thyroiditis
Education on Hashimoto thyroiditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Hashimoto's encephalopathy
Education on Hashimoto's encephalopathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Heart disease
Education on Heart disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Hemophilia
Education on Hemophilia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Henoch-Schonlein purpura
Education on Henoch-Schonlein purpura and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Hidradenitis suppurativa
Education on Hidradenitis suppurativa and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Idiopathic inflammatory demyelinating diseases
Education on Idiopathic inflammatory demyelinating diseases and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- IgG4-related disease
Education on IgG4-related disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Inclusion body myositis
Education on Inclusion body myositis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Infertility and sterility
Education on Infertility and sterility and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Inflammation and chronic inflammation
Education on Inflammation and chronic inflammation and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Inflammatory bowel disease
Also known as: IBD
Education on Inflammatory bowel disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Inflammatory breast cancer
Also known as: IBC, breast cancer
Education on Inflammatory breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Intermediate uveitis
Education on Intermediate uveitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Interstitial cystitis
Education on Interstitial cystitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Invasive ductal carcinoma
Also known as: IDC, breast cancer
Education on Invasive ductal carcinoma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Juvenile arthritis
Education on Juvenile arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Kawasaki's disease
Education on Kawasaki's disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Kidney disease
Education on Kidney disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Lambert-Eaton myasthenic syndrome
Education on Lambert-Eaton myasthenic syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Leukocytoclastic vasculitis
Education on Leukocytoclastic vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Lichen planus
Education on Lichen planus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Lichen sclerosis
Education on Lichen sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Ligneous conjunctivitis
Education on Ligneous conjunctivitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Linear IgA disease
Education on Linear IgA disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Lung cancer
Also known as: Non-small cell lung cancer, NSCLC, Lung cancer prevention
Education on lung cancer prevention searches and Mark Egly research hypotheses about Alpha-1 Antitrypsin biology. Not medical advice.
- Lupus
Education on lupus within the Mark Egly Foundation autoimmune research catalog, with hypothesis labeling.
- Lupus nephritis
Education on Lupus nephritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Lupus vasculitis
Education on Lupus vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Lyme disease
Education on Lyme disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Maternal hypoxia
Education on Maternal hypoxia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Medullary (breast)
Also known as: breast cancer
Education on Medullary (breast) and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Melanoma and skin cancers
Education on Melanoma and skin cancers and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Meniere's Disease
Education on Meniere's Disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Metastatic breast cancer
Also known as: MBC, breast cancer
Education on Metastatic breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Microscopic colitis
Education on Microscopic colitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Microscopic polyangiitis
Also known as: MPA
Education on Microscopic polyangiitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Mixed connective tissue disease
Education on Mixed connective tissue disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Mooren's ulcer
Education on Mooren's ulcer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Morphea
Education on Morphea and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Mucha-Habermann disease
Education on Mucha-Habermann disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Mucinous carcinoma
Also known as: breast cancer
Education on Mucinous carcinoma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Multiple sclerosis
Education on Multiple sclerosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Muscular dystrophy
Education on Muscular dystrophy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Myasthenia gravis
Education on Myasthenia gravis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Myocarditis
Education on Myocarditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Myositis
Education on Myositis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Neointimal lesions
Education on Neointimal lesions and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Neuromyelitis optica
Education on Neuromyelitis optica and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Optic neuritis
Education on Optic neuritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Ord's thyroiditis
Education on Ord's thyroiditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Ovarian cancer
Education on Ovarian cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Paget disease (breast)
Also known as: breast cancer
Education on Paget disease (breast) and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Palindromic rheumatism
Education on Palindromic rheumatism and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pancreatic cancer
Education on Pancreatic cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Paraneoplastic cerebellar degeneration
Education on Paraneoplastic cerebellar degeneration and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Parkinson's disease
Also known as: Parkinson disease, Parkinsons
Education on emerging research questions linking Parkinson's disease and Alpha-1 Antitrypsin, clearly labeled as hypothesis.
- Parry-Romberg syndrome
Education on Parry-Romberg syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Parsonage-Turner syndrome
Education on Parsonage-Turner syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pediatric autoimmune neuropsychiatric disorder associated with streptococcus
Education on Pediatric autoimmune neuropsychiatric disorder associated with streptococcus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pemphigus vulgaris
Education on Pemphigus vulgaris and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Periodontal disease
Education on Periodontal disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pernicious anemia
Education on Pernicious anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pityriasis lichenoides et Varioliformis acuta
Education on Pityriasis lichenoides et Varioliformis acuta and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pneumonia
Education on Pneumonia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Poems Syndrome
Education on Poems Syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Polyarteritis nodosa
Education on Polyarteritis nodosa and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Polymyalgia rheumatica
Education on Polymyalgia rheumatica and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Polymyositis Postmyocardial infarction syndrome
Education on Polymyositis Postmyocardial infarction syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Postpericardiotomy syndrome (Sevuk et al)
Education on Postpericardiotomy syndrome (Sevuk et al) and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Primary biliary cirrhosis
Education on Primary biliary cirrhosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Primary sclerosing cholangitis
Education on Primary sclerosing cholangitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Progressive inflammatory neuropathy
Education on Progressive inflammatory neuropathy and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Prostate cancer
Education on prostate cancer and Alpha-1 Antitrypsin research hypotheses, with clear separation from urology and oncology standard care.
- Psoriasis
Education on Psoriasis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Psoriatic arthritis
Education on Psoriatic arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pure red cell aplasia
Education on Pure red cell aplasia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Pyoderma gangrenosum
Education on Pyoderma gangrenosum and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Raynaud phenomenon
Education on Raynaud phenomenon and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Reactive arthritis
Education on Reactive arthritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Relapsing polychondritis
Education on Relapsing polychondritis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Restless leg syndrome
Education on Restless leg syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Retroperitoneal fibrosis
Education on Retroperitoneal fibrosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Rheumatic fever
Education on Rheumatic fever and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Rheumatoid arthritis
Education on rheumatoid arthritis and Alpha-1 research hypotheses within the foundation autoimmune catalog.
- Rheumatoid vasculitis
Education on Rheumatoid vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Sarcoidosis
Education on Sarcoidosis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Schnitzler syndrome
Education on Schnitzler syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Scleroderma
Education on Scleroderma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Scoliosis, kyphosis, and related back issues
Education on Scoliosis, kyphosis, and related back issues and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Sickle cell anemia
Education on Sickle cell anemia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Sjogren's syndrome
Education on Sjogren's syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Small cell carcinoma of the breast
Also known as: breast cancer
Education on Small cell carcinoma of the breast and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Stiff person syndrome
Education on Stiff person syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Strokes
Education on Strokes and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Subacute bacterial endocarditis
Education on Subacute bacterial endocarditis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Susac's Syndrome
Education on Susac's Syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Sydenham chorea
Education on Sydenham chorea and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Sympathetic ophthalmia
Education on Sympathetic ophthalmia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Syringomyelia
Education on Syringomyelia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Systemic lupus erythematosus
Education on Systemic lupus erythematosus and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Systemic scleroderma
Education on Systemic scleroderma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Testicular cancer
Education on Testicular cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Thrombocytopenia
Education on Thrombocytopenia and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Tolosa-Hunt syndrome
Education on Tolosa-Hunt syndrome and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Transverse myelitis
Education on Transverse myelitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Triple negative breast cancer
Also known as: breast cancer
Education on Triple negative breast cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Tubular carcinoma
Also known as: breast cancer
Education on Tubular carcinoma and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Ulcerative colitis
Education on Ulcerative colitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Undifferentiated connective tissue disease
Education on Undifferentiated connective tissue disease and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Urticaria
Education on Urticaria and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Urticarial vasculitis
Education on Urticarial vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Uterine cancer
Education on Uterine cancer and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Vasculitis
Education on Vasculitis and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.
- Vitiligo
Education on Vitiligo and Alpha-1 Antitrypsin research from the Mark Egly Foundation, with patent claims clearly labeled as hypothesis.